Member Info for GloriaMarket

"This share is defying gravity."

Depends whether or not you believe the earth is round.

"Without news there will be NO resistance!

When will the stupid people on here see that ?"

There is resistance but it's very limp resistance.

Many derampers on here were the biggest rampers until at some point the penny dropped and they saw the error of their faith in the company. Mr Systemzero, Mr Chawali, Mr starres (allegedly now deramping under the name of Mr stocksaint) are a few rampers who became intense derampers that would make Boris Johnsons' u-turn on europe before the brexit referendum look amateurish. And their deramping proved accurate, don't forget. Most of the time the derampers are correct. If sales remain lacking and the SP continues its decline I suspect Mr Carrots will become a fervent deramper.

"I imagine financial bonuses for selling GDR products are rather hard to come by…."

Not in the good old days of the pandemic. I recall Mr Budd receiving handsome bonuses in 2020 and perhaps even 2021 based on the "jam tomorrow" rise in share price and only possibilities of commercial sales outside friends and family appearing in the RNSes. Assuming the Brighton NHS trust deal in December 2023 did not require friends or family connections of Mr Cheek then that contract should be considered the most significant contract GDR has ever won in the last 5+ years. Investors are still waiting for another contract, outside GDRs circle of friends and family even after NICE full recommendation. LTHs have every right to be bitter imo.

"Alistair Haig Business Development Manager has left Genedrive after 2 years and 5 months hence the new replacement."

They replaced Mr Cheek with no-one (Dr Miele now has two jobs) and now experience has been replaced by a recent graduate suggests that GDR are in cost-cutting mode . In other words, trying to make the last placement last for as long as possible whilst still intent on more sales than ever before, after recent NICE approval.

"her looks have got nothing to do with it"

In sales, looks matter alot, male or female.

"Omg they’ve hired a recent graduate to head up their business development. Jesus. You just cdnt make it up. "

GDR tried experience and the sales didn't even cover Mr Cheeks salary. I wish her the best of luck in showing them that a good looking, clever blonde graduate can run rings around "experience". I'm impressed tbh.

Mr Joeybloggs, GDR is a penny stock where gamblers expect at least three figures in percentage profit.

"Best asking Mystic Meg 🤣"

I think I just did.

"The route for one test ((MT-RNR1 ID Kit)) has been decided,"

de novo route was decided for GDR due to being welcomed into the breakthrough program. Correct?

" the other (CYP2C19-ID Kit) has not. My apologies for my part in the confusion."

I assume no invitation received to join the breakthrough program, at least not yet. Is GDR waiting for an invitation from the FDA to help them decide which route to take?!?

"Gloria, it only received full NICE recommendation a month ago. Sales will come..."

When and how significant?

" ...it's fairly well known that it's not feasible at this scale... enter Genedrive, the recommended POC."

sales figures so far dont back this up at all, unfortunately. is this going to be 20's version of the 80s betamax vs VHS story? NICE prioritization of lab testing suggests as much, at least so far. The clinicians of manchester are certainly doing more than their fair shares of sales pitches on behalf of GDR . Dr Gilhams daily mail journalist contact hasn't produced sales. I seriously think Dr Gilham and Dr Miele should go on dragons den. "We are looking for 6 million to keep the lights on for 12 months as we break in to the american market. " ....

@MR BigAl67,

Can I suggest you put the Bottle away, and have a Good sleep, and give posting on our BB a miss, for a while !!

Just maybe your post will make some sort of sense, and you will be able to find the much needed reference you cannot find !!! LOL

"A stroke is a life threatening condition speed of treatment is of the essence. Consultants will want results from a test ASAP. Cost will not be an issue. It's all about lead time 30 mins or a few days which would you choose in the stroke business bad and ill informed decisions could result in death!"

I agree and so do the consultants in manchester, which is why it's such a shame that NICE prioritized relatively slow lab testing above GDR POC test.

My quotes came from american gov site

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456655/#:~:text=Length%20of%20stay.&text=The%20average%20LOS%20of%20inpatient,stays%20than%20ischemic%20stroke%20patients.

, don't know what the stats are for the NHS but I think I've provided evidence to back up my belief that victims of minor strokes don't spend much time in hospital at all.

""First Few Weeks After a Stroke. The typical length of a hospital stay after a stroke is five to seven days. During this time, the stroke care team will evaluate the effects of the stroke, which will determine the rehabilitation plan.""

I'm sure your correct but I think I read that clopdodod and its beneifically effects, are not depending on your genes,

are more related to TIAs (minor strokes not major ones...

" In patients with minor stroke or TIA, the combination of clopidogrel and aspirin appears to be superior to aspirin alone in improving the 90-day functional outcome, and this is consistent with a reduction in the rate of disabling stroke in the dual antiplatelet arm."

GDR POC kit only tests for the genes that render clopidogrel ineffective.

"The average LOS of inpatient TIA patients was shorter than that of inpatient ischemic stroke patients (3.6 vs 8.8 days, p < 0.0001), "

"The fact that you have a time critical result for stroke patient treatment a couple of days earlier than the lab test technically should save at least 2 days of each patient taking up a hospital bed."

Thats a ridiculous assumption that patients which may be prescribed Clopopododopodo are bidden ridden and need 24 care before getting the result. I think I read that most patients 8 are precscribed clopoodododo and are sent home regardless of whether the medicine will work for them. If its discovered days later that they have a gene that means clopdodododo is ineffective for them then they are prescribed an alternative medicine. Unfortunately I don't have the reference to hand.

" Jimbob is spamming that on multiple sites. Result? Sp down 2%."

Similar to Mr Carrots. General rule is when a ramper is spamming uncontrollably that the SP is failling and will continue to fall. If the stock can be shorted, its a great way to make some money by doing the opposite to what the unhinged spammers preach. :D

"For the timeline I would refer you back to the answer I had from the company:

"We are currently in discussion with a number of CYP2C19 testing centres in the USA and Key Opinion Leaders to consider if we go with a reduced solution via a 510k submission using Genomadix as a comparator or if we go via the Denovo route with all of our testing capability.

The 510k route could be quick and give us access to the USA market with 6 to 9 months but we would only be able to operate in the same way as Genomadix or the Denovo route takes 18 months to 2 years but would allow us to compete with the full range of the CYP2c19 test. Once we have gathered all of the information from the references in the USA we will make a decision.""

That's really great information. How come it takes you Mr Eureka to make this dilemma that the company are having public?!

"I have now had confirmation from a company spokesperson that, as I thought, the company is still undecided. "The matter is still undecided for now, and they will make a decision based on what they think is best once they have all the information."

"FDA application not even started" "

Perhaps this is why Mr Cheek left... out of frustration that the company is dithering. Gilham GO!